MRI CHANGES FOLLOWING TREATMENT OF GLP‐1 ANALOGUE, LIRAGLUTIDE IN ALZHEIMER’S DISEASE
Paul Edison(Imperial College London), Clive Ballard(University of Exeter), Robert Perneczky(Klinikum rechts der Isar), Benjamin R. Underwood(University of Cambridge), Sajeev Kshemendran, Anita Mansouri(University of Oxford), Ramin Nilforooshan(University of Surrey), Basil H. Ridha(University Hospitals Sussex NHS Foundation Trust), Craig Ritchie(Western General Hospital), Paul Koranteng(Northamptonshire Healthcare NHS Foundation Trust), Mae Chester‐Jones(Office for National Statistics), Bernadette McGuinness(Queen's University Belfast), Grazia Daniela Femminella(Hammersmith Hospital), Andrew Donaldson(University of Cape Town), John Harrison(King's College London), Jane Holmes(University of Manchester), Kehinde Junaid(Nottinghamshire Healthcare NHS Foundation Trust), Brady McFarlane(Southern Health NHS Foundation Trust), George Tadros(Aston University), Clive Holmes(University of Eastern Finland), Christian Hölscher(Shanxi Medical University), Simon Thacker, Zuzana Walker(South Essex Partnership University Foundation NHS Trust), Gregor Russell(Bradford District Care NHS Foundation Trust), Hilary Archer(North Bristol NHS Trust), Vandana Mate(Cornwall Partnership NHS Foundation Trust), Robert M. Lawrence(South West London and St George's Mental Health NHS Trust), Anthony Peter Passmore(Queen's University Belfast), Gareth Williams(King's College London), Aparna Prasanna(Black Country Partnership NHS Foundation Trust), Lucy Knight(Somerset Partnership NHS Foundation Trust), Elizabeth Coulthard(North Bristol NHS Trust), Joseph Nowell(Imperial College London), Salman Karim(Lancashire Care NHS Foundation Trust)
Cited by 18
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k